Zhaonian Hao

688 total citations · 1 hit paper
12 papers, 444 citations indexed

About

Zhaonian Hao is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Zhaonian Hao has authored 12 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Zhaonian Hao's work include Glioma Diagnosis and Treatment (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Zhaonian Hao is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Zhaonian Hao collaborates with scholars based in China, Belarus and United States. Zhaonian Hao's co-authors include Ruyuan Li, Zhiqiang Han, Zhenya Hong, Dongsheng Guo, Shufen Li, Yan Wu, Leike Zhang, Runming Jin, Hao Li and Hao‐Long Zeng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Medicine and Metabolism.

In The Last Decade

Zhaonian Hao

11 papers receiving 444 citations

Hit Papers

Calcium channel blocker amlodipine besylate therapy is as... 2020 2026 2022 2024 2020 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension
    2020 233 citations Leike Zhang, Yuan Sun et al. Cell Discovery profile →

Peers

Zhaonian Hao
Yulia Liubomirski Israel
Ximeng Han China
Trivikram Dasu United States
Muxue Tang China
Jais Rose Bjelke Denmark
Yujiro Toyoshima Japan
Junbum Kim United States
Lifang Huang China
Yulia Liubomirski Israel
Zhaonian Hao
Citations per year, relative to Zhaonian Hao Zhaonian Hao (= 1×) peers Yulia Liubomirski

Countries citing papers authored by Zhaonian Hao

Since Specialization
Citations

This map shows the geographic impact of Zhaonian Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaonian Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaonian Hao more than expected).

Fields of papers citing papers by Zhaonian Hao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhaonian Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaonian Hao. The network helps show where Zhaonian Hao may publish in the future.

Co-authorship network of co-authors of Zhaonian Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Zhaonian Hao. A scholar is included among the top collaborators of Zhaonian Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhaonian Hao. Zhaonian Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Liu, Jinqiu, Zhaonian Hao, Herui Wang, et al.. (2025). The AURKA inhibitor alters the immune microenvironment and enhances targeting B7-H3 immunotherapy in glioblastoma. JCI Insight. 10(5). 2 indexed citations
2.
Hao, Zhaonian, Jiejun Wang, Yifan Lv, et al.. (2024). Identification of MGMT promoter methylation as a specific lipid metabolism biomarker, reveals the feasibility of atorvastatin application in glioblastoma. Metabolism. 153. 155794–155794. 5 indexed citations
3.
Wang, Jiejun, Zhaonian Hao, Ruyuan Li, et al.. (2024). Association of body mass index with clinical outcome of primary WHO grade 4 glioma. Frontiers in Oncology. 14. 1318785–1318785.
4.
Hao, Zhaonian, et al.. (2022). Small Molecule Inhibitors in Adult High-Grade Glioma: From the Past to the Future. Frontiers in Oncology. 12. 911876–911876. 14 indexed citations
5.
Zou, Ling, Zhaonian Hao, Baofeng Wang, et al.. (2022). S645C Point Mutation Suppresses Degradation of EGFR to Promote Progression of Glioblastoma. Frontiers in Oncology. 12. 1 indexed citations
6.
Wang, Zhenhao, Jin Zhang, Zhaonian Hao, et al.. (2022). Tuberculosis infection related hemophagocytic lymphohistiocytosis diagnosed in patient with GZMB mutation: A case report and literature review. Medicine. 101(35). e30283–e30283. 3 indexed citations
7.
Hao, Zhaonian, Ruyuan Li, Yuanyuan Wang, et al.. (2021). Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy. Biomarker Research. 9(1). 77–77. 65 indexed citations
8.
Hao, Zhaonian, et al.. (2021). Global Evidence of Temperature Acclimation of COVID‐19 D614G Linage. SHILAP Revista de lepidopterología. 5(6). 2000132–2000132. 4 indexed citations
9.
Zhang, Leike, Yuan Sun, Hao‐Long Zeng, et al.. (2021). Author Correction: Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension. Cell Discovery. 7(1). 29–29. 2 indexed citations
10.
Hao, Zhaonian, Ruyuan Li, Meng Li, Zhiqiang Han, & Zhenya Hong. (2020). Macrophage, the potential key mediator in CAR-T related CRS. Experimental Hematology and Oncology. 9(1). 15–15. 75 indexed citations
11.
Zhang, Leike, Yuan Sun, Hao‐Long Zeng, et al.. (2020). Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension. Cell Discovery. 6(1). 96–96. 233 indexed citations breakdown →
12.
Hao, Zhaonian & Dongsheng Guo. (2019). EGFR mutation: novel prognostic factor associated with immune infiltration in lower-grade glioma; an exploratory study. BMC Cancer. 19(1). 1184–1184. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yulia Liubomirski Breakdown of academic impact, for papers by Ximeng Han Breakdown of academic impact, for papers by Trivikram Dasu Breakdown of academic impact, for papers by Muxue Tang Breakdown of academic impact, for papers by Jais Rose Bjelke Breakdown of academic impact, for papers by Yujiro Toyoshima Breakdown of academic impact, for papers by Junbum Kim Breakdown of academic impact, for papers by Lifang Huang
Rankless by CCL
2026